| Boehringer Ingelheim Announces Results of Phase III Data Showing That ... - Financial Post |
|
|
Financial Post1-6 Notably, in diabetes patients with mild and moderate renal impairment, linagliptin blood plasma levels were comparable to those seen in diabetes ...Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin ... read more |